nodes	percent_of_prediction	percent_of_DWPC	metapath
Formoterol—CYP2A6—Rosiglitazone—type 2 diabetes mellitus	0.069	0.102	CbGbCtD
Formoterol—ADRB1—Bromocriptine—type 2 diabetes mellitus	0.0635	0.0936	CbGbCtD
Formoterol—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0364	0.0537	CbGbCtD
Formoterol—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0356	0.0525	CbGbCtD
Formoterol—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0325	0.048	CbGbCtD
Formoterol—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0309	0.0456	CbGbCtD
Formoterol—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0309	0.0456	CbGbCtD
Formoterol—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0303	0.0446	CbGbCtD
Formoterol—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.0286	0.0421	CbGbCtD
Formoterol—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.0276	0.0407	CbGbCtD
Formoterol—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0257	0.0379	CbGbCtD
Formoterol—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0257	0.0379	CbGbCtD
Formoterol—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0237	0.035	CbGbCtD
Formoterol—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0235	0.0347	CbGbCtD
Formoterol—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0229	0.0338	CbGbCtD
Formoterol—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0217	0.032	CbGbCtD
Formoterol—CYP2C9—Valsartan—type 2 diabetes mellitus	0.021	0.0309	CbGbCtD
Formoterol—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.0195	0.0287	CbGbCtD
Formoterol—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.0187	0.0276	CbGbCtD
Formoterol—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0178	0.0263	CbGbCtD
Formoterol—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0171	0.0252	CbGbCtD
Formoterol—CYP2C19—Glyburide—type 2 diabetes mellitus	0.0158	0.0234	CbGbCtD
Formoterol—CYP2C19—Losartan—type 2 diabetes mellitus	0.0145	0.0214	CbGbCtD
Formoterol—CYP2C9—Glyburide—type 2 diabetes mellitus	0.0132	0.0194	CbGbCtD
Formoterol—CYP2C9—Losartan—type 2 diabetes mellitus	0.012	0.0178	CbGbCtD
Formoterol—Isoprenaline—PIK3R1—type 2 diabetes mellitus	0.00177	0.305	CrCbGaD
Formoterol—Fenoterol—ADRB3—type 2 diabetes mellitus	0.00131	0.225	CrCbGaD
Formoterol—Arbutamine—ADRB3—type 2 diabetes mellitus	0.00122	0.211	CrCbGaD
Formoterol—Labetalol—ADRB3—type 2 diabetes mellitus	0.000868	0.15	CrCbGaD
Formoterol—Isoprenaline—ADRB3—type 2 diabetes mellitus	0.000639	0.11	CrCbGaD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000133	0.00057	CcSEcCtD
Formoterol—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000132	0.000569	CcSEcCtD
Formoterol—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000132	0.000568	CcSEcCtD
Formoterol—Discomfort—Metformin—type 2 diabetes mellitus	0.000132	0.000567	CcSEcCtD
Formoterol—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000132	0.000567	CcSEcCtD
Formoterol—Nausea—Glipizide—type 2 diabetes mellitus	0.000132	0.000565	CcSEcCtD
Formoterol—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000131	0.000565	CcSEcCtD
Formoterol—Hypotension—Valsartan—type 2 diabetes mellitus	0.000131	0.000565	CcSEcCtD
Formoterol—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000131	0.000563	CcSEcCtD
Formoterol—Pain—Gliclazide—type 2 diabetes mellitus	0.000131	0.000563	CcSEcCtD
Formoterol—Constipation—Gliclazide—type 2 diabetes mellitus	0.000131	0.000563	CcSEcCtD
Formoterol—Tremor—Losartan—type 2 diabetes mellitus	0.000131	0.000561	CcSEcCtD
Formoterol—Rash—Glimepiride—type 2 diabetes mellitus	0.00013	0.00056	CcSEcCtD
Formoterol—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00013	0.00056	CcSEcCtD
Formoterol—Rash—Sitagliptin—type 2 diabetes mellitus	0.00013	0.000558	CcSEcCtD
Formoterol—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.00013	0.000558	CcSEcCtD
Formoterol—Headache—Glimepiride—type 2 diabetes mellitus	0.000129	0.000557	CcSEcCtD
Formoterol—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000129	0.000556	CcSEcCtD
Formoterol—Cough—Irbesartan—type 2 diabetes mellitus	0.000129	0.000555	CcSEcCtD
Formoterol—Headache—Sitagliptin—type 2 diabetes mellitus	0.000129	0.000555	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000128	0.000551	CcSEcCtD
Formoterol—Agitation—Losartan—type 2 diabetes mellitus	0.000128	0.00055	CcSEcCtD
Formoterol—Oedema—Metformin—type 2 diabetes mellitus	0.000128	0.00055	CcSEcCtD
Formoterol—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000128	0.000549	CcSEcCtD
Formoterol—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000128	0.000548	CcSEcCtD
Formoterol—Angioedema—Losartan—type 2 diabetes mellitus	0.000127	0.000547	CcSEcCtD
Formoterol—Infection—Metformin—type 2 diabetes mellitus	0.000127	0.000547	CcSEcCtD
Formoterol—Insomnia—Valsartan—type 2 diabetes mellitus	0.000127	0.000547	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000127	0.000544	CcSEcCtD
Formoterol—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000126	0.000542	CcSEcCtD
Formoterol—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000126	0.000542	CcSEcCtD
Formoterol—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000126	0.000542	CcSEcCtD
Formoterol—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000126	0.000542	CcSEcCtD
Formoterol—Insomnia—Orlistat—type 2 diabetes mellitus	0.000126	0.00054	CcSEcCtD
Formoterol—Malaise—Losartan—type 2 diabetes mellitus	0.000126	0.00054	CcSEcCtD
Formoterol—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000126	0.00054	CcSEcCtD
Formoterol—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000126	0.00054	CcSEcCtD
Formoterol—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000126	0.00054	CcSEcCtD
Formoterol—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000125	0.000539	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000125	0.000538	CcSEcCtD
Formoterol—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000125	0.000538	CcSEcCtD
Formoterol—Somnolence—Valsartan—type 2 diabetes mellitus	0.000125	0.000537	CcSEcCtD
Formoterol—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000125	0.000535	CcSEcCtD
Formoterol—Skin disorder—Metformin—type 2 diabetes mellitus	0.000124	0.000535	CcSEcCtD
Formoterol—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000124	0.000533	CcSEcCtD
Formoterol—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000124	0.000532	CcSEcCtD
Formoterol—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000124	0.000532	CcSEcCtD
Formoterol—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000123	0.00053	CcSEcCtD
Formoterol—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000123	0.00053	CcSEcCtD
Formoterol—Palpitations—Losartan—type 2 diabetes mellitus	0.000123	0.000529	CcSEcCtD
Formoterol—Nausea—Glimepiride—type 2 diabetes mellitus	0.000123	0.000528	CcSEcCtD
Formoterol—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000123	0.000527	CcSEcCtD
Formoterol—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000122	0.000526	CcSEcCtD
Formoterol—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000122	0.000526	CcSEcCtD
Formoterol—Asthenia—Glyburide—type 2 diabetes mellitus	0.000122	0.000526	CcSEcCtD
Formoterol—Cough—Losartan—type 2 diabetes mellitus	0.000122	0.000523	CcSEcCtD
Formoterol—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000122	0.000523	CcSEcCtD
Formoterol—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000121	0.000522	CcSEcCtD
Formoterol—Fatigue—Valsartan—type 2 diabetes mellitus	0.000121	0.000521	CcSEcCtD
Formoterol—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000121	0.00052	CcSEcCtD
Formoterol—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000121	0.00052	CcSEcCtD
Formoterol—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000121	0.000519	CcSEcCtD
Formoterol—Oedema—Irbesartan—type 2 diabetes mellitus	0.000121	0.000519	CcSEcCtD
Formoterol—Pruritus—Glyburide—type 2 diabetes mellitus	0.000121	0.000518	CcSEcCtD
Formoterol—Mental disorder—Ramipril—type 2 diabetes mellitus	0.00012	0.000517	CcSEcCtD
Formoterol—Constipation—Valsartan—type 2 diabetes mellitus	0.00012	0.000517	CcSEcCtD
Formoterol—Infection—Irbesartan—type 2 diabetes mellitus	0.00012	0.000516	CcSEcCtD
Formoterol—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.00012	0.000516	CcSEcCtD
Formoterol—Fatigue—Orlistat—type 2 diabetes mellitus	0.00012	0.000515	CcSEcCtD
Formoterol—Hypotension—Metformin—type 2 diabetes mellitus	0.00012	0.000514	CcSEcCtD
Formoterol—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000119	0.000514	CcSEcCtD
Formoterol—Pain—Orlistat—type 2 diabetes mellitus	0.000119	0.000511	CcSEcCtD
Formoterol—Arthralgia—Losartan—type 2 diabetes mellitus	0.000119	0.00051	CcSEcCtD
Formoterol—Chest pain—Losartan—type 2 diabetes mellitus	0.000119	0.00051	CcSEcCtD
Formoterol—Myalgia—Losartan—type 2 diabetes mellitus	0.000119	0.00051	CcSEcCtD
Formoterol—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000119	0.00051	CcSEcCtD
Formoterol—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000118	0.000509	CcSEcCtD
Formoterol—Anxiety—Losartan—type 2 diabetes mellitus	0.000118	0.000508	CcSEcCtD
Formoterol—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000118	0.000507	CcSEcCtD
Formoterol—Rash—Bromocriptine—type 2 diabetes mellitus	0.000118	0.000505	CcSEcCtD
Formoterol—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000117	0.000505	CcSEcCtD
Formoterol—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000117	0.000505	CcSEcCtD
Formoterol—Tension—Ramipril—type 2 diabetes mellitus	0.000117	0.000504	CcSEcCtD
Formoterol—Discomfort—Losartan—type 2 diabetes mellitus	0.000117	0.000504	CcSEcCtD
Formoterol—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000117	0.000503	CcSEcCtD
Formoterol—Headache—Bromocriptine—type 2 diabetes mellitus	0.000117	0.000502	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000117	0.000501	CcSEcCtD
Formoterol—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000117	0.000501	CcSEcCtD
Formoterol—Nervousness—Ramipril—type 2 diabetes mellitus	0.000116	0.000499	CcSEcCtD
Formoterol—Dry mouth—Losartan—type 2 diabetes mellitus	0.000116	0.000499	CcSEcCtD
Formoterol—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000115	0.000494	CcSEcCtD
Formoterol—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000115	0.000494	CcSEcCtD
Formoterol—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000114	0.000492	CcSEcCtD
Formoterol—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000114	0.000491	CcSEcCtD
Formoterol—Somnolence—Metformin—type 2 diabetes mellitus	0.000114	0.000489	CcSEcCtD
Formoterol—Oedema—Losartan—type 2 diabetes mellitus	0.000114	0.000489	CcSEcCtD
Formoterol—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000114	0.000489	CcSEcCtD
Formoterol—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000114	0.000488	CcSEcCtD
Formoterol—Infection—Losartan—type 2 diabetes mellitus	0.000113	0.000486	CcSEcCtD
Formoterol—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000113	0.000485	CcSEcCtD
Formoterol—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000113	0.000485	CcSEcCtD
Formoterol—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000113	0.000485	CcSEcCtD
Formoterol—Tremor—Ramipril—type 2 diabetes mellitus	0.000112	0.000481	CcSEcCtD
Formoterol—Urticaria—Valsartan—type 2 diabetes mellitus	0.000112	0.00048	CcSEcCtD
Formoterol—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000111	0.000479	CcSEcCtD
Formoterol—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000111	0.000478	CcSEcCtD
Formoterol—Tachycardia—Losartan—type 2 diabetes mellitus	0.000111	0.000477	CcSEcCtD
Formoterol—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000111	0.000477	CcSEcCtD
Formoterol—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000111	0.000476	CcSEcCtD
Formoterol—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000111	0.000475	CcSEcCtD
Formoterol—Fatigue—Metformin—type 2 diabetes mellitus	0.00011	0.000475	CcSEcCtD
Formoterol—Urticaria—Orlistat—type 2 diabetes mellitus	0.00011	0.000474	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.00011	0.000473	CcSEcCtD
Formoterol—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.00011	0.000472	CcSEcCtD
Formoterol—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.00011	0.000472	CcSEcCtD
Formoterol—Asthenia—Gliclazide—type 2 diabetes mellitus	0.00011	0.000472	CcSEcCtD
Formoterol—Agitation—Ramipril—type 2 diabetes mellitus	0.00011	0.000472	CcSEcCtD
Formoterol—Constipation—Metformin—type 2 diabetes mellitus	0.000109	0.000471	CcSEcCtD
Formoterol—Angioedema—Ramipril—type 2 diabetes mellitus	0.000109	0.000469	CcSEcCtD
Formoterol—Vomiting—Glyburide—type 2 diabetes mellitus	0.000108	0.000466	CcSEcCtD
Formoterol—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000108	0.000465	CcSEcCtD
Formoterol—Malaise—Ramipril—type 2 diabetes mellitus	0.000108	0.000463	CcSEcCtD
Formoterol—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000108	0.000463	CcSEcCtD
Formoterol—Rash—Glyburide—type 2 diabetes mellitus	0.000107	0.000462	CcSEcCtD
Formoterol—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000107	0.000462	CcSEcCtD
Formoterol—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000107	0.000462	CcSEcCtD
Formoterol—Headache—Glyburide—type 2 diabetes mellitus	0.000107	0.000459	CcSEcCtD
Formoterol—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000106	0.000457	CcSEcCtD
Formoterol—Hypotension—Losartan—type 2 diabetes mellitus	0.000106	0.000457	CcSEcCtD
Formoterol—Palpitations—Ramipril—type 2 diabetes mellitus	0.000106	0.000454	CcSEcCtD
Formoterol—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000105	0.000454	CcSEcCtD
Formoterol—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000105	0.00045	CcSEcCtD
Formoterol—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000105	0.00045	CcSEcCtD
Formoterol—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000104	0.000448	CcSEcCtD
Formoterol—Cough—Ramipril—type 2 diabetes mellitus	0.000104	0.000448	CcSEcCtD
Formoterol—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000104	0.000448	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000104	0.000445	CcSEcCtD
Formoterol—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000104	0.000445	CcSEcCtD
Formoterol—Pain—Irbesartan—type 2 diabetes mellitus	0.000103	0.000444	CcSEcCtD
Formoterol—Constipation—Irbesartan—type 2 diabetes mellitus	0.000103	0.000444	CcSEcCtD
Formoterol—Insomnia—Losartan—type 2 diabetes mellitus	0.000103	0.000442	CcSEcCtD
Formoterol—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000102	0.00044	CcSEcCtD
Formoterol—Urticaria—Metformin—type 2 diabetes mellitus	0.000102	0.000437	CcSEcCtD
Formoterol—Myalgia—Ramipril—type 2 diabetes mellitus	0.000102	0.000437	CcSEcCtD
Formoterol—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000102	0.000437	CcSEcCtD
Formoterol—Chest pain—Ramipril—type 2 diabetes mellitus	0.000102	0.000437	CcSEcCtD
Formoterol—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000101	0.000436	CcSEcCtD
Formoterol—Anxiety—Ramipril—type 2 diabetes mellitus	0.000101	0.000436	CcSEcCtD
Formoterol—Nausea—Glyburide—type 2 diabetes mellitus	0.000101	0.000435	CcSEcCtD
Formoterol—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000101	0.000435	CcSEcCtD
Formoterol—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000101	0.000435	CcSEcCtD
Formoterol—Somnolence—Losartan—type 2 diabetes mellitus	0.000101	0.000435	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000101	0.000434	CcSEcCtD
Formoterol—Asthenia—Valsartan—type 2 diabetes mellitus	0.000101	0.000434	CcSEcCtD
Formoterol—Discomfort—Ramipril—type 2 diabetes mellitus	0.0001	0.000432	CcSEcCtD
Formoterol—Dyspepsia—Losartan—type 2 diabetes mellitus	0.0001	0.00043	CcSEcCtD
Formoterol—Asthenia—Orlistat—type 2 diabetes mellitus	9.97e-05	0.000429	CcSEcCtD
Formoterol—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	9.95e-05	0.000428	CcSEcCtD
Formoterol—Pruritus—Valsartan—type 2 diabetes mellitus	9.95e-05	0.000428	CcSEcCtD
Formoterol—Dry mouth—Ramipril—type 2 diabetes mellitus	9.95e-05	0.000428	CcSEcCtD
Formoterol—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	9.88e-05	0.000425	CcSEcCtD
Formoterol—Pruritus—Orlistat—type 2 diabetes mellitus	9.83e-05	0.000423	CcSEcCtD
Formoterol—Fatigue—Losartan—type 2 diabetes mellitus	9.8e-05	0.000421	CcSEcCtD
Formoterol—Oedema—Ramipril—type 2 diabetes mellitus	9.75e-05	0.000419	CcSEcCtD
Formoterol—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	9.75e-05	0.000419	CcSEcCtD
Formoterol—Vomiting—Gliclazide—type 2 diabetes mellitus	9.73e-05	0.000418	CcSEcCtD
Formoterol—Pain—Losartan—type 2 diabetes mellitus	9.72e-05	0.000418	CcSEcCtD
Formoterol—Constipation—Losartan—type 2 diabetes mellitus	9.72e-05	0.000418	CcSEcCtD
Formoterol—Rash—Gliclazide—type 2 diabetes mellitus	9.65e-05	0.000415	CcSEcCtD
Formoterol—Dermatitis—Gliclazide—type 2 diabetes mellitus	9.64e-05	0.000414	CcSEcCtD
Formoterol—Diarrhoea—Valsartan—type 2 diabetes mellitus	9.62e-05	0.000414	CcSEcCtD
Formoterol—Urticaria—Irbesartan—type 2 diabetes mellitus	9.6e-05	0.000413	CcSEcCtD
Formoterol—Headache—Gliclazide—type 2 diabetes mellitus	9.58e-05	0.000412	CcSEcCtD
Formoterol—Nervous system disorder—Ramipril—type 2 diabetes mellitus	9.56e-05	0.000411	CcSEcCtD
Formoterol—Abdominal pain—Irbesartan—type 2 diabetes mellitus	9.55e-05	0.000411	CcSEcCtD
Formoterol—Body temperature increased—Irbesartan—type 2 diabetes mellitus	9.55e-05	0.000411	CcSEcCtD
Formoterol—Tachycardia—Ramipril—type 2 diabetes mellitus	9.51e-05	0.000409	CcSEcCtD
Formoterol—Diarrhoea—Orlistat—type 2 diabetes mellitus	9.5e-05	0.000409	CcSEcCtD
Formoterol—Skin disorder—Ramipril—type 2 diabetes mellitus	9.47e-05	0.000407	CcSEcCtD
Formoterol—Feeling abnormal—Losartan—type 2 diabetes mellitus	9.37e-05	0.000403	CcSEcCtD
Formoterol—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	9.3e-05	0.0004	CcSEcCtD
Formoterol—Dizziness—Valsartan—type 2 diabetes mellitus	9.3e-05	0.0004	CcSEcCtD
Formoterol—Dizziness—Orlistat—type 2 diabetes mellitus	9.19e-05	0.000395	CcSEcCtD
Formoterol—Asthenia—Metformin—type 2 diabetes mellitus	9.18e-05	0.000395	CcSEcCtD
Formoterol—Hypotension—Ramipril—type 2 diabetes mellitus	9.11e-05	0.000392	CcSEcCtD
Formoterol—Nausea—Gliclazide—type 2 diabetes mellitus	9.09e-05	0.000391	CcSEcCtD
Formoterol—Pruritus—Metformin—type 2 diabetes mellitus	9.06e-05	0.000389	CcSEcCtD
Formoterol—Urticaria—Losartan—type 2 diabetes mellitus	9.03e-05	0.000388	CcSEcCtD
Formoterol—Abdominal pain—Losartan—type 2 diabetes mellitus	8.99e-05	0.000386	CcSEcCtD
Formoterol—Body temperature increased—Losartan—type 2 diabetes mellitus	8.99e-05	0.000386	CcSEcCtD
Formoterol—Vomiting—Valsartan—type 2 diabetes mellitus	8.94e-05	0.000384	CcSEcCtD
Formoterol—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	8.9e-05	0.000383	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	8.88e-05	0.000382	CcSEcCtD
Formoterol—Rash—Valsartan—type 2 diabetes mellitus	8.86e-05	0.000381	CcSEcCtD
Formoterol—Dermatitis—Valsartan—type 2 diabetes mellitus	8.85e-05	0.000381	CcSEcCtD
Formoterol—Vomiting—Orlistat—type 2 diabetes mellitus	8.83e-05	0.00038	CcSEcCtD
Formoterol—Insomnia—Ramipril—type 2 diabetes mellitus	8.82e-05	0.000379	CcSEcCtD
Formoterol—Headache—Valsartan—type 2 diabetes mellitus	8.81e-05	0.000379	CcSEcCtD
Formoterol—Diarrhoea—Metformin—type 2 diabetes mellitus	8.76e-05	0.000377	CcSEcCtD
Formoterol—Rash—Orlistat—type 2 diabetes mellitus	8.76e-05	0.000377	CcSEcCtD
Formoterol—Dermatitis—Orlistat—type 2 diabetes mellitus	8.75e-05	0.000376	CcSEcCtD
Formoterol—Headache—Orlistat—type 2 diabetes mellitus	8.7e-05	0.000374	CcSEcCtD
Formoterol—Dyspnoea—Ramipril—type 2 diabetes mellitus	8.69e-05	0.000374	CcSEcCtD
Formoterol—Asthenia—Irbesartan—type 2 diabetes mellitus	8.67e-05	0.000373	CcSEcCtD
Formoterol—Somnolence—Ramipril—type 2 diabetes mellitus	8.67e-05	0.000373	CcSEcCtD
Formoterol—Dyspepsia—Ramipril—type 2 diabetes mellitus	8.58e-05	0.000369	CcSEcCtD
Formoterol—Pruritus—Irbesartan—type 2 diabetes mellitus	8.55e-05	0.000367	CcSEcCtD
Formoterol—Dizziness—Metformin—type 2 diabetes mellitus	8.46e-05	0.000364	CcSEcCtD
Formoterol—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	8.42e-05	0.000362	CcSEcCtD
Formoterol—Fatigue—Ramipril—type 2 diabetes mellitus	8.4e-05	0.000361	CcSEcCtD
Formoterol—Hypersensitivity—Losartan—type 2 diabetes mellitus	8.38e-05	0.00036	CcSEcCtD
Formoterol—Nausea—Valsartan—type 2 diabetes mellitus	8.35e-05	0.000359	CcSEcCtD
Formoterol—Constipation—Ramipril—type 2 diabetes mellitus	8.34e-05	0.000358	CcSEcCtD
Formoterol—Diarrhoea—Irbesartan—type 2 diabetes mellitus	8.27e-05	0.000355	CcSEcCtD
Formoterol—Nausea—Orlistat—type 2 diabetes mellitus	8.25e-05	0.000355	CcSEcCtD
Formoterol—Asthenia—Losartan—type 2 diabetes mellitus	8.16e-05	0.000351	CcSEcCtD
Formoterol—Vomiting—Metformin—type 2 diabetes mellitus	8.14e-05	0.00035	CcSEcCtD
Formoterol—Rash—Metformin—type 2 diabetes mellitus	8.07e-05	0.000347	CcSEcCtD
Formoterol—Dermatitis—Metformin—type 2 diabetes mellitus	8.06e-05	0.000347	CcSEcCtD
Formoterol—Pruritus—Losartan—type 2 diabetes mellitus	8.04e-05	0.000346	CcSEcCtD
Formoterol—Feeling abnormal—Ramipril—type 2 diabetes mellitus	8.03e-05	0.000345	CcSEcCtD
Formoterol—Headache—Metformin—type 2 diabetes mellitus	8.02e-05	0.000345	CcSEcCtD
Formoterol—Dizziness—Irbesartan—type 2 diabetes mellitus	7.99e-05	0.000343	CcSEcCtD
Formoterol—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	7.97e-05	0.000343	CcSEcCtD
Formoterol—Diarrhoea—Losartan—type 2 diabetes mellitus	7.78e-05	0.000334	CcSEcCtD
Formoterol—Urticaria—Ramipril—type 2 diabetes mellitus	7.74e-05	0.000333	CcSEcCtD
Formoterol—Abdominal pain—Ramipril—type 2 diabetes mellitus	7.71e-05	0.000331	CcSEcCtD
Formoterol—Body temperature increased—Ramipril—type 2 diabetes mellitus	7.71e-05	0.000331	CcSEcCtD
Formoterol—Vomiting—Irbesartan—type 2 diabetes mellitus	7.68e-05	0.00033	CcSEcCtD
Formoterol—Rash—Irbesartan—type 2 diabetes mellitus	7.62e-05	0.000328	CcSEcCtD
Formoterol—Dermatitis—Irbesartan—type 2 diabetes mellitus	7.61e-05	0.000327	CcSEcCtD
Formoterol—Nausea—Metformin—type 2 diabetes mellitus	7.6e-05	0.000327	CcSEcCtD
Formoterol—Headache—Irbesartan—type 2 diabetes mellitus	7.57e-05	0.000325	CcSEcCtD
Formoterol—Dizziness—Losartan—type 2 diabetes mellitus	7.52e-05	0.000323	CcSEcCtD
Formoterol—Vomiting—Losartan—type 2 diabetes mellitus	7.23e-05	0.000311	CcSEcCtD
Formoterol—Hypersensitivity—Ramipril—type 2 diabetes mellitus	7.18e-05	0.000309	CcSEcCtD
Formoterol—Nausea—Irbesartan—type 2 diabetes mellitus	7.18e-05	0.000309	CcSEcCtD
Formoterol—Rash—Losartan—type 2 diabetes mellitus	7.17e-05	0.000308	CcSEcCtD
Formoterol—Dermatitis—Losartan—type 2 diabetes mellitus	7.16e-05	0.000308	CcSEcCtD
Formoterol—Headache—Losartan—type 2 diabetes mellitus	7.12e-05	0.000306	CcSEcCtD
Formoterol—Asthenia—Ramipril—type 2 diabetes mellitus	6.99e-05	0.000301	CcSEcCtD
Formoterol—Pruritus—Ramipril—type 2 diabetes mellitus	6.9e-05	0.000297	CcSEcCtD
Formoterol—Nausea—Losartan—type 2 diabetes mellitus	6.75e-05	0.00029	CcSEcCtD
Formoterol—Diarrhoea—Ramipril—type 2 diabetes mellitus	6.67e-05	0.000287	CcSEcCtD
Formoterol—Dizziness—Ramipril—type 2 diabetes mellitus	6.45e-05	0.000277	CcSEcCtD
Formoterol—Vomiting—Ramipril—type 2 diabetes mellitus	6.2e-05	0.000267	CcSEcCtD
Formoterol—Rash—Ramipril—type 2 diabetes mellitus	6.15e-05	0.000264	CcSEcCtD
Formoterol—Dermatitis—Ramipril—type 2 diabetes mellitus	6.14e-05	0.000264	CcSEcCtD
Formoterol—Headache—Ramipril—type 2 diabetes mellitus	6.11e-05	0.000263	CcSEcCtD
Formoterol—Nausea—Ramipril—type 2 diabetes mellitus	5.79e-05	0.000249	CcSEcCtD
Formoterol—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	1.13e-05	0.000135	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.12e-05	0.000135	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.12e-05	0.000135	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CPT1A—type 2 diabetes mellitus	1.12e-05	0.000134	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—MTR—type 2 diabetes mellitus	1.12e-05	0.000134	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—GLP1R—type 2 diabetes mellitus	1.12e-05	0.000134	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—GSTM1—type 2 diabetes mellitus	1.11e-05	0.000133	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.11e-05	0.000133	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—AVP—type 2 diabetes mellitus	1.11e-05	0.000133	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.11e-05	0.000133	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.1e-05	0.000132	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.1e-05	0.000132	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—NAMPT—type 2 diabetes mellitus	1.1e-05	0.000132	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—APOB—type 2 diabetes mellitus	1.09e-05	0.000131	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—LPL—type 2 diabetes mellitus	1.09e-05	0.000131	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.09e-05	0.000131	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—GCK—type 2 diabetes mellitus	1.09e-05	0.000131	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—LIPC—type 2 diabetes mellitus	1.09e-05	0.000131	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—HBA1—type 2 diabetes mellitus	1.09e-05	0.000131	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.09e-05	0.000131	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.09e-05	0.00013	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CYP11A1—type 2 diabetes mellitus	1.08e-05	0.00013	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.08e-05	0.000129	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—APOB—type 2 diabetes mellitus	1.07e-05	0.000128	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—ADCY5—type 2 diabetes mellitus	1.07e-05	0.000128	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.07e-05	0.000128	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—GPX1—type 2 diabetes mellitus	1.07e-05	0.000128	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—SLC9A1—type 2 diabetes mellitus	1.06e-05	0.000128	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.05e-05	0.000126	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CETP—type 2 diabetes mellitus	1.05e-05	0.000126	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	1.05e-05	0.000126	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—LPL—type 2 diabetes mellitus	1.05e-05	0.000125	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—SLC2A2—type 2 diabetes mellitus	1.04e-05	0.000125	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—CD36—type 2 diabetes mellitus	1.04e-05	0.000124	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	1.03e-05	0.000123	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	1.03e-05	0.000123	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—PPP2CA—type 2 diabetes mellitus	1.02e-05	0.000123	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.02e-05	0.000123	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—LPL—type 2 diabetes mellitus	1.02e-05	0.000123	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	1.02e-05	0.000122	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	1.02e-05	0.000122	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	1.01e-05	0.000121	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	1e-05	0.00012	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	1e-05	0.00012	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	1e-05	0.00012	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	1e-05	0.00012	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1e-05	0.00012	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	9.97e-06	0.00012	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	9.95e-06	0.000119	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	9.95e-06	0.000119	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	9.95e-06	0.000119	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	9.95e-06	0.000119	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	9.89e-06	0.000119	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—MTHFR—type 2 diabetes mellitus	9.83e-06	0.000118	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	9.81e-06	0.000118	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	9.81e-06	0.000118	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	9.79e-06	0.000117	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PSMD6—type 2 diabetes mellitus	9.79e-06	0.000117	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—SREBF1—type 2 diabetes mellitus	9.79e-06	0.000117	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—SNAP25—type 2 diabetes mellitus	9.79e-06	0.000117	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	9.71e-06	0.000116	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	9.68e-06	0.000116	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—PPARA—type 2 diabetes mellitus	9.65e-06	0.000116	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CCR5—type 2 diabetes mellitus	9.63e-06	0.000115	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CTGF—type 2 diabetes mellitus	9.61e-06	0.000115	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	9.6e-06	0.000115	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	9.59e-06	0.000115	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—HMGCR—type 2 diabetes mellitus	9.52e-06	0.000114	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CCR5—type 2 diabetes mellitus	9.42e-06	0.000113	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—C3—type 2 diabetes mellitus	9.41e-06	0.000113	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	9.39e-06	0.000113	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—AGT—type 2 diabetes mellitus	9.34e-06	0.000112	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	9.32e-06	0.000112	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—C3—type 2 diabetes mellitus	9.21e-06	0.00011	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—CALM1—type 2 diabetes mellitus	9.19e-06	0.00011	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—APOE—type 2 diabetes mellitus	9.15e-06	0.00011	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—APOA1—type 2 diabetes mellitus	9.05e-06	0.000109	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	9e-06	0.000108	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	9e-06	0.000108	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	9e-06	0.000108	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	8.98e-06	0.000108	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—IRS2—type 2 diabetes mellitus	8.95e-06	0.000107	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	8.95e-06	0.000107	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	8.95e-06	0.000107	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—AGT—type 2 diabetes mellitus	8.94e-06	0.000107	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	8.92e-06	0.000107	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	8.92e-06	0.000107	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	8.92e-06	0.000107	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	8.85e-06	0.000106	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	8.85e-06	0.000106	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	8.83e-06	0.000106	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CALM1—type 2 diabetes mellitus	8.79e-06	0.000105	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	8.78e-06	0.000105	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—APOE—type 2 diabetes mellitus	8.76e-06	0.000105	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—LEP—type 2 diabetes mellitus	8.76e-06	0.000105	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	8.76e-06	0.000105	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—IRS2—type 2 diabetes mellitus	8.76e-06	0.000105	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	8.76e-06	0.000105	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—AGT—type 2 diabetes mellitus	8.75e-06	0.000105	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	8.68e-06	0.000104	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—APOA1—type 2 diabetes mellitus	8.66e-06	0.000104	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	8.63e-06	0.000104	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CALM1—type 2 diabetes mellitus	8.6e-06	0.000103	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	8.59e-06	0.000103	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—LEP—type 2 diabetes mellitus	8.57e-06	0.000103	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—APOE—type 2 diabetes mellitus	8.57e-06	0.000103	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	8.57e-06	0.000103	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	8.56e-06	0.000103	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	8.49e-06	0.000102	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	8.48e-06	0.000102	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	8.48e-06	0.000102	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—APOA1—type 2 diabetes mellitus	8.47e-06	0.000102	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	8.26e-06	9.91e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	8.23e-06	9.87e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	8.16e-06	9.79e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	8.14e-06	9.76e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	8.14e-06	9.76e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	8.08e-06	9.69e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	8.07e-06	9.68e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	8.07e-06	9.68e-05	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—PPARG—type 2 diabetes mellitus	7.97e-06	9.56e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	7.94e-06	9.52e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	7.87e-06	9.44e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	7.83e-06	9.39e-05	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—INS—type 2 diabetes mellitus	7.82e-06	9.38e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—IRS1—type 2 diabetes mellitus	7.82e-06	9.37e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	7.8e-06	9.36e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	7.8e-06	9.36e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	7.74e-06	9.28e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	7.74e-06	9.28e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—IRS1—type 2 diabetes mellitus	7.65e-06	9.17e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—INS—type 2 diabetes mellitus	7.49e-06	8.98e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CCL2—type 2 diabetes mellitus	7.36e-06	8.83e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—INS—type 2 diabetes mellitus	7.32e-06	8.78e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	7.31e-06	8.77e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.31e-06	8.77e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	7.28e-06	8.73e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—IGF1—type 2 diabetes mellitus	7.24e-06	8.68e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—AKT2—type 2 diabetes mellitus	7.23e-06	8.68e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	7.2e-06	8.64e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CCL2—type 2 diabetes mellitus	7.2e-06	8.64e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	7.18e-06	8.61e-05	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—ALB—type 2 diabetes mellitus	7.17e-06	8.6e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—IGF1—type 2 diabetes mellitus	7.08e-06	8.49e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—AKT2—type 2 diabetes mellitus	7.08e-06	8.49e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	7.05e-06	8.45e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	6.97e-06	8.36e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.88e-06	8.25e-05	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—PIK3R1—type 2 diabetes mellitus	6.86e-06	8.22e-05	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—NOS3—type 2 diabetes mellitus	6.86e-06	8.22e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	6.78e-06	8.13e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	6.73e-06	8.07e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.73e-06	8.07e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.73e-06	8.07e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	6.7e-06	8.03e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	6.67e-06	8e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.67e-06	8e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	6.66e-06	7.98e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	6.64e-06	7.96e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	6.61e-06	7.92e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.56e-06	7.87e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.56e-06	7.87e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	6.55e-06	7.85e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	6.52e-06	7.82e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	6.5e-06	7.79e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.42e-06	7.7e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.42e-06	7.7e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	6.41e-06	7.69e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	6.36e-06	7.63e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	6.33e-06	7.59e-05	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—PTGS2—type 2 diabetes mellitus	6.27e-06	7.52e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	6.25e-06	7.49e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	6.24e-06	7.48e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	6.18e-06	7.42e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—RELA—type 2 diabetes mellitus	6.18e-06	7.41e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	6.12e-06	7.34e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	6.07e-06	7.28e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—RELA—type 2 diabetes mellitus	6.04e-06	7.25e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	6e-06	7.19e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	5.99e-06	7.19e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	5.97e-06	7.17e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	5.94e-06	7.13e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	5.92e-06	7.1e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	5.88e-06	7.05e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	5.82e-06	6.98e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	5.77e-06	6.92e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	5.75e-06	6.89e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	5.7e-06	6.83e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	5.7e-06	6.83e-05	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.62e-06	6.75e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	5.6e-06	6.72e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	5.58e-06	6.69e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.57e-06	6.68e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.54e-06	6.64e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	5.52e-06	6.62e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	5.51e-06	6.61e-05	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.5e-06	6.6e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	5.47e-06	6.56e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.45e-06	6.54e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.42e-06	6.5e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	5.41e-06	6.49e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	5.36e-06	6.43e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.27e-06	6.32e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	5.24e-06	6.28e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.21e-06	6.25e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	5.19e-06	6.23e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.15e-06	6.18e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	5.15e-06	6.18e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	5.13e-06	6.16e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.11e-06	6.13e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	5.11e-06	6.12e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.1e-06	6.11e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	5.09e-06	6.1e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	5.07e-06	6.09e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	5.03e-06	6.03e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5e-06	5.99e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	4.86e-06	5.83e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—SRC—type 2 diabetes mellitus	4.86e-06	5.82e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	4.77e-06	5.72e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—SRC—type 2 diabetes mellitus	4.75e-06	5.7e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.73e-06	5.67e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.63e-06	5.55e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	4.47e-06	5.36e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	4.43e-06	5.32e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	4.39e-06	5.26e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	4.37e-06	5.24e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	4.35e-06	5.21e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.34e-06	5.21e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.26e-06	5.1e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.25e-06	5.09e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	4.18e-06	5.01e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	4.18e-06	5.01e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.16e-06	4.99e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	4.02e-06	4.82e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	3.99e-06	4.78e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	3.85e-06	4.61e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	3.85e-06	4.61e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	3.82e-06	4.59e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	3.81e-06	4.57e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	3.81e-06	4.57e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	3.52e-06	4.22e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	3.49e-06	4.18e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—IL6—type 2 diabetes mellitus	3.27e-06	3.92e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—IL6—type 2 diabetes mellitus	3.2e-06	3.84e-05	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—AKT1—type 2 diabetes mellitus	3.15e-06	3.78e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.02e-06	3.62e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.95e-06	3.54e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	1.92e-06	2.3e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	1.77e-06	2.12e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	1.75e-06	2.1e-05	CbGpPWpGaD
